Merck KGAA (PK) Quote - MKGAF

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

149.90

Bid

142.00

Offer

153.72

Volume

249

143.50 Day's Range 149.90

142.05 52 Week Range 200.56

Market Cap

19.373B

Previous Close

143.75

Open

149.90

Last Trade

149.9

Last Trade Time

Financial Volume

US$ 36,059

VWAP

144.8161

Average Volume (3m)

288

Shares Outstanding

129,242,251

Dividend Yield

1.41%

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

20.99B

Net Profit

2.82B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.merck.de

Headquarters

Darmstadt, Deu

Founded

1987

Merck KGAA (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MKGAF. The last closing price for Merck KGAA (PK) was US$143.75. Over the last year, Merck KGAA (PK) shares have traded in a share price range of US$ 142.05 to US$ 200.56.

Merck KGAA (PK) currently has 129,242,251 shares in issue. The market capitalisation of Merck KGAA (PK) is US$18.58 billion.

Data on Merck KGaA's L-BLP25 - Analyst Blog

Merck KGaA (MKGAF ) recently presented detailed results on its oncology candidate L-BLP25, from the phase III study, START (Stimulating Targeted Antigenic Responses To NSCLC). Results...

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog

Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the reported quarter were up 4.4% year over year...

Merck KGaA-CBRX Renew Agreement - Analyst Blog

Merck KGaA (MKGAF) and Columbia Laboratories, Inc. (CBRX) recently renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years. This...

Sanofi Reports Lemtrada Data - Analyst Blog

Sanofi’s (SNY) subsidiary, Genzyme, recently announced interim data on its multiple sclerosis (MS) candidate, Lemtrada (alemtuzumab), from the first year of an extension study. ...

Merck KGaA-BMY Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a deal with Bristol-Myers Squibb (BMY) for the promotion of different formulations of Glucophage (metformin hydrochloride) in China. Glucophage is used for...

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin (recombinant human FGF-18). Sprifermin is being...

Threshold Cuts Loss, Misses Sales - Analyst Blog

Threshold Pharmaceuticals Inc. (THLD) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss of 11...

Strong Quarter for Merck KGaA - Analyst Blog

Merck KGaA (MKGAF) reported fourth quarter 2012 earnings per American Depository Receipt (ADR) of $2.66, up 18.8% year over year. Revenues for the reported quarter were up 8% year over year...

Positive Data from BMRN's PKU-016 - Analyst Blog

BioMarin Pharmaceutical Inc. (BMRN) recently announced positive results from the PKU-016 ASCEND study. This is the largest randomized controlled study evaluating the safety and therapeutic...

Threshold/Merck KGaA Drug in Study - Analyst Blog

Threshold Pharmaceuticals, Inc. (THLD) and Merck KGaA (MKGAF) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302. The study...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.1	-1.38157894737	152	152	142.05	1478	145.39286845	CS
4	-16.02	-9.65525554484	165.92	171.67	142.05	522	149.63282114	CS
12	-49.115	-24.6790442931	199.015	200.56	142.05	288	160.50374913	CS
26	-31.183	-17.220280203	181.083	200.56	142.05	247	168.29461396	CS
52	-26.523	-15.0337541024	176.423	200.56	142.05	757	162.06095688	CS
156	-102.1	-40.5158730159	252	264.4	142.05	617	174.17413029	CS
260	30.9	25.9663865546	119	264.4	82	603	158.00161724	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NEPTFNeptune Wellness Solutions Inc (CE)	US$ 0.0238 (2,379,900.00%)	13.46k
CNVIFConavi Medical Corporation (PK)	US$ 0.58 (82,757.14%)	2.25k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.00055 (54,900.00%)	342.7k
RQHTFReliq Health Technologies Inc (CE)	US$ 0.0003 (29,900.00%)	219.11k
ELOXEloxx Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	1.53k
FDVXFFenixOro Gold Corporation (CE)	US$ 0.000001 (-100.00%)	10k
TMPOQTempo Automation Holdings Inc (CE)	US$ 0.000001 (-99.98%)	200
HLLPFHello Pal International Inc (CE)	US$ 0.000001 (-99.90%)	6k
MOTSMotus GI Holdings Inc (CE)	US$ 0.000001 (-99.88%)	649
BTAEFBeta Energy Corporation (CE)	US$ 0.000001 (-99.67%)	655
RSHNRushNet Inc (PK)	US$ 0.00015 (-25.00%)	502.31M
EARIEntertainment Arts Research Inc (PK)	US$ 0.0001 (0.00%)	428.38M
ASTAAstra Veda Corporation (PK)	US$ 0.0002 (-33.33%)	364.38M
RDARRaadr Inc (PK)	US$ 0.0009 (50.00%)	276.07M
CGACCode Green Apparel Corp (PK)	US$ 0.00065 (44.44%)	225.16M